Compare Danaher Corporation (DHR) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs ProShares Ultra Gold ETF — how do they compare? Danaher Corporation trades at $200.52 (market cap $140.88B), while ProShares Ultra Gold ETF trades at $44.6. The key difference: Danaher Corporation pays a 0.8% dividend while ProShares Ultra Gold ETF pays none, and Danaher Corporation is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals.
| DHR | UGL | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $242.05 | $85.62 |
52-Week Low | $161.91 | $33.59 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
UGL trades at $43.38, down 5.2% over 24 hours amid a bearish technical outlook with 19 sell signals versus 2 buys. The stock faces resistance at $44 and $45, with support at $43 and $42. Financial ratios are unavailable, limiting fundamental clarity. Recent news highlights gold market volatility, with prices influenced by Fed policy, inflation data, and geopolitical tensions, though UGL's direct exposure is not detailed.
The outlook remains cautious due to weak technical momentum and lack of financial data. Risks include gold price sensitivity to interest rates and macroeconomic shifts. Investors should await earnings reports for fundamental validation, as current analysis relies heavily on technical indicators and broader sector sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
